WT1 and ACE mRNAs of blood extracellular vesicle as biomarkers of diabetic nephropathy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
WT1 and ACE mRNAs of blood extracellular vesicle as biomarkers of diabetic nephropathy ; volume:19 ; number:1 ; day:10 ; month:7 ; year:2021 ; pages:1-9 ; date:12.2021
Journal of translational medicine ; 19, Heft 1 (10.7.2021), 1-9, 12.2021
- Creator
-
Hashemi, Ehsan
Dehghanbanadaki, Hojat
Baharanchi, Alireza Abbasi
Forouzanfar, Katayoon
Kakaei, Ardeshir
Mohammadi, Seyed Mohammad
Zeidi, Saba
Razi, Farideh
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-021-02964-6
- URN
-
urn:nbn:de:101:1-2021101620231102465387
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hashemi, Ehsan
- Dehghanbanadaki, Hojat
- Baharanchi, Alireza Abbasi
- Forouzanfar, Katayoon
- Kakaei, Ardeshir
- Mohammadi, Seyed Mohammad
- Zeidi, Saba
- Razi, Farideh
- SpringerLink (Online service)
Other Objects (12)
WT1 peptide analogue WT1-126Y enhances leukemia lysis
Correction: Angiotensin-Converting Enzyme (ACE) 2 Overexpression Ameliorates Glomerular Injury in a Rat Model of Diabetic Nephropathy: A Comparison with ACE Inhibition
Urinary podocyte mRNAs precede microalbuminuria as a progression risk marker in human type 2 diabetic nephropathy
Ace
"ACe"!
ACe
Ace
A.C.E. Bauer & Co. vormals: A.C.E. Bauer
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins : = Verbesserung der T-Zellantwort gegen WT1-überexprimierende Leukämie mit neu entwickelten anti-hDEC205-WT1-Antikörperfusionsproteinen
Long term efficacy of WT1 peptide vaccine in patients with WT1 overexpressing hematopoeitic and solid malignancies
Vesicle hypothesis
ACE inhibitors
WT1 peptide analogue WT1-126Y enhances leukemia lysis
Correction: Angiotensin-Converting Enzyme (ACE) 2 Overexpression Ameliorates Glomerular Injury in a Rat Model of Diabetic Nephropathy: A Comparison with ACE Inhibition
Urinary podocyte mRNAs precede microalbuminuria as a progression risk marker in human type 2 diabetic nephropathy
Ace
"ACe"!
ACe
Ace
A.C.E. Bauer & Co. vormals: A.C.E. Bauer
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins : = Verbesserung der T-Zellantwort gegen WT1-überexprimierende Leukämie mit neu entwickelten anti-hDEC205-WT1-Antikörperfusionsproteinen
Long term efficacy of WT1 peptide vaccine in patients with WT1 overexpressing hematopoeitic and solid malignancies
Vesicle hypothesis
ACE inhibitors
WT1 peptide analogue WT1-126Y enhances leukemia lysis
Correction: Angiotensin-Converting Enzyme (ACE) 2 Overexpression Ameliorates Glomerular Injury in a Rat Model of Diabetic Nephropathy: A Comparison with ACE Inhibition
Urinary podocyte mRNAs precede microalbuminuria as a progression risk marker in human type 2 diabetic nephropathy
Ace
"ACe"!
ACe
Ace
A.C.E. Bauer & Co. vormals: A.C.E. Bauer
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins : = Verbesserung der T-Zellantwort gegen WT1-überexprimierende Leukämie mit neu entwickelten anti-hDEC205-WT1-Antikörperfusionsproteinen
Long term efficacy of WT1 peptide vaccine in patients with WT1 overexpressing hematopoeitic and solid malignancies
Vesicle hypothesis